This fellowship is intended to provide training in pharmaceutical medicine and exposure to various functions and roles that a physician or PhD scientist can play in the industry. The fellow is ...

Ask Rick Doblin why he’s on a 32-year mission to get MDMA–the party drug commonly known as “Molly” or “Ecstasy”–approved as a medicine, and he’ll tick off three things: The Holocaust. The ...

The global pharmaceutical market size was valued at USD 1,607.07 billion in 2024 and is expected to be worth around USD 2,821.63 billion by 2034, growing at a compound annual growth rate (CAGR) of ...

Please join us for a fascinating lecture by Professor Alan Boyd to be held at 18.00 for a 18.30 start on Thursday 1 December at the RSC, London. This is an RSC Management Group event in partnership ...

In an interview with Pharmaceutical Technology®, Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the M&A landscape from 2024 and his expectations of what is to come next. When ...

In today’s ever-changing market place, pharmaceutical companies are challenged to reach, engage and persuade physicians in new, more effective ways. With changing behavioral influences, rising ...

Recently, Guangdong Jiaying Pharmaceutical Co., Ltd. held the 'First Hakka Medicine Historical and Cultural Symposium' and the 'Jiaying Hakka Medicine - Double-ingredient Throat Wind Relief Powder ...

In retrospect, testimony before a US congressional committee and two departments of the European Commission late last year were 11th-hour warnings of a pending upheaval for the world’s drug supply.

Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments, in an interview with ...

Colombia Pharmaceutical market is the 4th largest market in Latin America with a CARG of 7.3% and to participate in this market, it must be considered that the country is self-sufficient 400 ...